Booster Study of SpikoGen COVID-19 Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

September 16, 2025

Conditions
COVID-19
Interventions
BIOLOGICAL

SpikoGen vaccine

Recombinant spike protein based Covid-19 vaccine

Trial Locations (1)

5042

ARASMI, Adelaide

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Australian Respiratory and Sleep Medicine Institute Ltd

UNKNOWN

collaborator

Cinnagen

INDUSTRY

lead

Vaxine Pty Ltd

INDUSTRY